Search research articles
Contact Us
Filters
Showing results (121-130 of 240) with videos related to
Page
of 24
Sort By:
American Journal of Clinical Oncology
|
December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma
D F Moore, R Pazdur, S Sugarman, et al.
European Journal of Haematology
|
October 1, 1987
Danazol in the treatment of myelodysplastic syndromes
A C Buzaid, H S Garewal, S M Lippman, et al.
Leukemia & Lymphoma
|
July 27, 2016
Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype
J A Rybski, C M Spier, T P Miller, et al.
The Johns Hopkins Medical Journal
|
October 1, 1980
Pseudoxanthoma elasticum: treatment of gastrointestinal hemorrhage by arterial embolization and observations on autosomal dominant inheritance
J R Cunningham, S M Lippman, W A Renie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 1990
Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course
S M Lippman, C M Spier, T P Miller, et al.
The New England Journal of Medicine
|
February 4, 1982
Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow
C L Conley, S M Lippman, P M Ness, et al.
The American Journal of Pathology
|
November 7, 1999
Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis
H Qiu, W Zhang, A K El-Naggar, et al.
The American Journal of Medicine
|
December 1, 1982
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus
S M Lippman, F C Arnett, C L Conley, et al.
The American Journal of Pathology
|
October 1, 1988
The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma
C M Spier, T M Grogan, S M Lippman, et al.
Anti-Cancer Drugs
|
February 1, 1993
Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer
D A Rinaldi, S M Lippman, H A Burris, et al.
Page
of 24
Search research articles
Search
Showing results (121-130 of 240) with videos related to
Sort By:
Page
of 24
American Journal of Clinical Oncology
|
December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma
D F Moore, R Pazdur, S Sugarman, et al.
European Journal of Haematology
|
October 1, 1987
Danazol in the treatment of myelodysplastic syndromes
A C Buzaid, H S Garewal, S M Lippman, et al.
Leukemia & Lymphoma
|
July 27, 2016
Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype
J A Rybski, C M Spier, T P Miller, et al.
The Johns Hopkins Medical Journal
|
October 1, 1980
Pseudoxanthoma elasticum: treatment of gastrointestinal hemorrhage by arterial embolization and observations on autosomal dominant inheritance
J R Cunningham, S M Lippman, W A Renie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 1990
Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course
S M Lippman, C M Spier, T P Miller, et al.
The New England Journal of Medicine
|
February 4, 1982
Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow
C L Conley, S M Lippman, P M Ness, et al.
The American Journal of Pathology
|
November 7, 1999
Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis
H Qiu, W Zhang, A K El-Naggar, et al.
The American Journal of Medicine
|
December 1, 1982
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus
S M Lippman, F C Arnett, C L Conley, et al.
The American Journal of Pathology
|
October 1, 1988
The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma
C M Spier, T M Grogan, S M Lippman, et al.
Anti-Cancer Drugs
|
February 1, 1993
Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer
D A Rinaldi, S M Lippman, H A Burris, et al.
Page
of 24